By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Faron Pharmaceuticals Ltd. 

Tykistökatu 6 B, BioCity

Turku    FIN-20520  Finland
Phone: 358-2-469-5151 Fax: 358-2-469-5152


SEARCH JOBS


Industry
Pharmaceutical






Company News
Faron Pharmaceuticals Ltd. Release: New Patent Application Accepted By Finnish Patent Office 10/31/2016 10:00:59 AM
Faron Pharmaceuticals Ltd. Release: First Traumakine Phase III Patient In Japan Recruited For The Treatment Of Acute Respiratory Distress Syndrome And Update On Pan-European Phase III Traumakine Trial 10/24/2016 10:11:19 AM
Faron Pharmaceuticals Ltd. Release: Interim Results 2016: Progress Continued In Traumakine Phase III And With Clevegen Indications Extended 9/6/2016 11:00:50 AM
Faron Pharmaceuticals Ltd. Enters Into An Agreement With Abzena For The Manufacture Of Clevegen 7/25/2016 9:28:57 AM
Faron Pharmaceuticals Ltd. Provides Update At R&D Day 6/14/2016 9:40:17 AM
Faron Pharmaceuticals Ltd. Licenses Traumakine Korean Rights To Pharmbio Korea Inc. (“Pharmbio”) 6/13/2016 9:31:43 AM
Faron Pharmaceuticals Ltd. Expands R&D Strategy For Novel Immunotherapy Drug Candidate, Clevegen 5/26/2016 9:52:32 AM
Faron Pharmaceuticals Ltd. Strengthens Executive Team By Appointing New Medical Director 5/3/2016 8:42:18 AM
Faron Pharmaceuticals Ltd. Files Two New Patents To Strengthen Protection For Novel Immunotherapy Drug Candidate, Clevegen 4/19/2016 10:24:51 AM
Faron Pharmaceuticals Ltd. Annual Results For The Year Ended 31 December 2015 3/10/2016 9:28:20 AM
12
//-->